Last updated: April 26, 2021
Sponsor: Universidad Complutense de Madrid
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diabetes And Hypertension
Pressure Ulcer
Ulcers
Treatment
N/AClinical Study ID
NCT04716790
Ultrasound Debridement
20/738-EC_P
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male and female patients ≥18 years old.
- Type 1 or type 2 diabetes mellitus with HbA1c ≤ 10%.
- DFU grades IA, IIA, IB, IIB, IC, IIC, ID, IID, according to the University of TexasClassification.
- DFU grades PEDIS 1-Absence of Infection, PEDIS 2-Mild infection and PEDIS 3-Moderateinfection, according to the PEDIS-IDSA Classification.
- Wound size between 1 cm² and 30 cm².
- Evolution time DFU between 1 and 24 months.
- Ankle-brachial index (ABI) ≤0.9 and ankle systolic blood pressure (ASBP) ≥70mmHg, ortoe systolic blood pressure (TSBP) ≥50mmHg, ABI>0.9, TSBP ≥50mmHg and toe-brachialindex (TBI) ≤0.7
Exclusion
Exclusion Criteria:
- Critical limb ischemia patients with ABI≤0.5 and ASBP<70mmHg or TSBP<50mmHg.
- Clinical suspicion of osteomyelitis.
- Pregnant or lactating women or women of childbearing potential who are not usingeffective contraception.
- Patients diagnosed with hepatitis or human immunodeficiency virus (HIV)
Study Design
Total Participants: 60
Study Start date:
April 20, 2021
Estimated Completion Date:
June 23, 2023
Connect with a study center
Complutense University
Madrid, 28040
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.